Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.
Based on preliminary calculations, the gross profit margin for the first six months was 37.2% overall. One-time effects in the form of start-up costs for the production of the UV projection scanner in Taiwan and value adjustments on inventories in connection with a discontinued project had an extraordinary negative impact on gross profit. For the full year 2025, the company now expects a gross profit margin in the range of 37 to 39% (previously: 39 to 41%).
The ongoing expansion of personnel in research and development led to additional costs in the first half of the year due to higher onboarding and training expenses. Based on preliminary calculations, the EBIT margin for the first half of 2025 was 15.7%. For the full year 2025, the forecast for the EBIT margin has been reduced to a range of 13 to 15% (previously: 15 to 17%).
In view of less dynamic sales development, a change in the product mix, and the temporary double burden of setting up the Zhubei site in Taiwan, lower profitability is expected for the second half of the year.
The company is confirming its forecast range for consolidated sales for the 2025 fiscal year of €470 million to €510 million. Based on preliminary calculations, sales in the first half of 2025 amounted to €266.4 million.
The half-yearly financial report 2025 will be published as planned on August 7, 2025.
28-Jul-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at http://www.eqs-news.com
Read more on wallstreet:online
